Sionna Therapeutics, Inc.
SIONNASDAQHealthcare● Active
$34.08
$-1.29(-3.64%)
Market Cap$1.5B
P/E Ratio—
52W High$48.445
52W Low$13.51
Sionna Therapeutics, Inc. (SION) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SION · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$0.60
Est. -$0.52 · -15.4%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▼ Miss EPS
SION reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 10, 2026 | -$0.65 | — | — | — | — | — |
| ▼ Q2 FY2026 | May 12, 2026 | -$0.52 | -$0.60 | -15.4% | — | — | — |
| ▲ Q1 FY2026 | Mar 2, 2026 | -$0.54 | -$0.46 | +14.7% | — | — | — |
| ▲ Q4 FY2025 | Nov 5, 2025 | -$0.52 | -$0.46 | +11.5% | — | — | — |
| ▲ Q3 FY2025 | Aug 11, 2025 | -$0.68 | -$0.41 | +39.7% | — | — | — |
| ▼ Q2 FY2025 | May 12, 2025 | -$0.45 | -$0.62 | -37.8% | — | — | — |
| ▼ Q1 FY2025 | Mar 20, 2025 | -$0.57 | -$3.38 | -493.0% | — | — | — |
| — Q4 FY2024 | Nov 27, 2024 | — | -$0.92 | — | — | — | — |
Q3 FY2026
Aug 10, 2026
EPS Actual
—
EPS Est.
-$0.65
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Miss
EPS Actual
-$0.60
EPS Est.
-$0.52
EPS Surpr.
-15.4%
Revenue
—
Q1 FY2026
Mar 2, 2026Beat
EPS Actual
-$0.46
EPS Est.
-$0.54
EPS Surpr.
+14.7%
Revenue
—
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
-$0.46
EPS Est.
-$0.52
EPS Surpr.
+11.5%
Revenue
—
Q3 FY2025
Aug 11, 2025Beat
EPS Actual
-$0.41
EPS Est.
-$0.68
EPS Surpr.
+39.7%
Revenue
—
Q2 FY2025
May 12, 2025Miss
EPS Actual
-$0.62
EPS Est.
-$0.45
EPS Surpr.
-37.8%
Revenue
—
Q1 FY2025
Mar 20, 2025Miss
EPS Actual
-$3.38
EPS Est.
-$0.57
EPS Surpr.
-493.0%
Revenue
—
Q4 FY2024
Nov 27, 2024
EPS Actual
-$0.92
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.62 | $-0.62 | $-0.62 | 2 |
| Q3 FY2027 | $-0.59 | $-0.59 | $-0.59 | 2 |
| Q2 FY2027 | $-0.58 | $-0.58 | $-0.58 | 2 |
| Q1 FY2027 | $-0.66 | $-0.66 | $-0.66 | 2 |
| Q4 FY2026 | $-0.68 | $-0.68 | $-0.68 | 4 |
| Q3 FY2026 | $-0.87 | $-0.66 | $-0.51 | 6 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 12, 2026 | -15.4% | $45.95 | $40.94 | -10.90% |
| ▲ Q1 FY2026 | Mar 2, 2026 | +14.7% | $36.54 | $33.92 | -7.17% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +11.5% | $35.64 | $35.08 | -1.57% |
| ▲ Q3 FY2025 | Aug 11, 2025 | +39.7% | $17.67 | $20.03 | +13.36% |
| ▼ Q2 FY2025 | May 12, 2025 | -37.8% | $12.32 | $12.90 | +4.71% |
| ▼ Q1 FY2025 | Mar 20, 2025 | -493.0% | $13.88 | $13.88 | +0.00% |
| — Q4 FY2024 | Nov 27, 2024 | — | No price data | $25.00 | — |
Q2 FY2026-10.90%
Report Date
May 12, 2026
EPS Beat/Miss
-15.4%
Price Before
$45.95
Price After
$40.94
Q1 FY2026-7.17%
Report Date
Mar 2, 2026
EPS Beat/Miss
+14.7%
Price Before
$36.54
Price After
$33.92
Q4 FY2025-1.57%
Report Date
Nov 5, 2025
EPS Beat/Miss
+11.5%
Price Before
$35.64
Price After
$35.08
Q3 FY2025+13.36%
Report Date
Aug 11, 2025
EPS Beat/Miss
+39.7%
Price Before
$17.67
Price After
$20.03
Q2 FY2025+4.71%
Report Date
May 12, 2025
EPS Beat/Miss
-37.8%
Price Before
$12.32
Price After
$12.90
Q1 FY2025+0.00%
Report Date
Mar 20, 2025
EPS Beat/Miss
-493.0%
Price Before
$13.88
Price After
$13.88
Q4 FY2024—
Report Date
Nov 27, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$25.00
Avg Beat Reaction+1.54%
Avg Miss Reaction-2.06%
Beat Rate3 / 7 quarters
Largest Move+13.36% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SION ends December
Sionna Therapeutics, Inc. (SION) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-0.60 — missing the analyst consensus of $-0.52 by -15.4%. The next SION earnings date is expected around September 1, 2026.
Each quarter, investors track SION earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SION revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SION's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SION earnings · 5 questionsSionna Therapeutics, Inc.'s next earnings report is expected around September 1, 2026. SION typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SION historically reports after market close (AMC).
SION earnings datewhen is SION earningsSION next earnings datewhen does SION report earningsSION earnings calendar
▸ Source: FMP · Sionna Therapeutics, Inc. SEC filings · US GAAP · Sionna Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026